{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:05:34Z","timestamp":1774314334915,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s12094-020-02393-9","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T10:02:36Z","timestamp":1590573756000},"page":"58-64","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5527-0786","authenticated-orcid":false,"given":"J.","family":"Aparicio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Garc\u00eda del Muro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Maroto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Terrasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bast\u00fas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gum\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Sagastibeltza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ochenduszko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Meana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Garc\u00eda-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Arranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Giron\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R.","family":"Germ\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,27]]},"reference":[{"key":"2393_CR1","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1093\/annonc\/mdy217","volume":"29","author":"F Honecker","year":"2018","unstructured":"Honecker F, Aparicio J, Berney D, et al. ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Ann Oncol. 2018;29:1658\u201386.","journal-title":"Ann Oncol"},{"key":"2393_CR2","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.eururo.2014.07.001","volume":"66","author":"MS Mortensen","year":"2014","unstructured":"Mortensen MS, Lauritsen J, Gundgaard MG, et al. A nationwide cohort study of stage I seminoma patients followed on a surveillance program. Eur Urol. 2014;66:1172\u20138.","journal-title":"Eur Urol"},{"key":"2393_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1200\/JCO.2014.56.2116","volume":"33","author":"C Kollmannsberger","year":"2015","unstructured":"Kollmannsberger C, Tandstad T, Bedard PL, et al. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance. J Clin Oncol. 2015;33:51\u20137.","journal-title":"J Clin Oncol"},{"key":"2393_CR4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1200\/JCO.2016.69.0958","volume":"35","author":"S Fischer","year":"2017","unstructured":"Fischer S, Tandstad T, Wheater M, et al. Outcome of men with relapse after adjuvant carboplatin for clinical stage I seminoma. J Clin Oncol. 2017;35:194\u2013200.","journal-title":"J Clin Oncol"},{"key":"2393_CR5","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/annonc\/mdg241","volume":"14","author":"J Aparicio","year":"2003","unstructured":"Aparicio J, Garc\u00eda-del-Muro X, Maroto P, et al. Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma. Ann Oncol. 2003;14:867\u201372.","journal-title":"Ann Oncol"},{"key":"2393_CR6","doi-asserted-by":"publisher","first-page":"8717","DOI":"10.1200\/JCO.2005.01.9810","volume":"23","author":"J Aparicio","year":"2005","unstructured":"Aparicio J, Germ\u00e0 JR, Garc\u00eda-del-Muro X, et al. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study. J Clin Oncol. 2005;23:8717\u201323.","journal-title":"J Clin Oncol"},{"key":"2393_CR7","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1200\/JCO.2011.36.0503","volume":"29","author":"J Aparicio","year":"2011","unstructured":"Aparicio J, Maroto P, Garc\u00eda-del-Muro X, et al. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study. J Clin Oncol. 2011;29:4677\u201381.","journal-title":"J Clin Oncol"},{"key":"2393_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000487438","volume":"95","author":"J Aparicio","year":"2018","unstructured":"Aparicio J, S\u00e1nchez-Mu\u00f1oz A, Gum\u00e0 J, et al. A risk-adapted approach to patients with stage I seminoma according to the status of rete testis: the Fourth Spanish Germ Cell Cancer Group Study. Oncology. 2018;95:8\u201312.","journal-title":"Oncology"},{"key":"2393_CR9","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","volume":"15","author":"International Germ Cell Cancer Collaborative Group","year":"1997","unstructured":"International Germ Cell Cancer Collaborative Group. International germ cell consensus classification: a prognostic factor based staging system for metastatic germ cell cancers. J Clin Oncol. 1997;15:594\u2013603.","journal-title":"J Clin Oncol"},{"key":"2393_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/jnci\/djq525","volume":"103","author":"GM Mead","year":"2011","unstructured":"Mead GM, Fossa SD, Oliver RTD, et al. Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-up. J Natl Cancer Inst. 2011;103:241\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"2393_CR11","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1093\/annonc\/mdv254","volume":"26","author":"C Chau","year":"2015","unstructured":"Chau C, Cathomas R, Wheater M, et al. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17 year UK experience. Ann Oncol. 2015;26:1865\u201370.","journal-title":"Ann Oncol"},{"key":"2393_CR12","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/annonc\/mdw164","volume":"27","author":"T Tandstad","year":"2016","unstructured":"Tandstad T, Stahl O, Dahl O, et al. Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA). Ann Oncol. 2016;27:1299\u2013304.","journal-title":"Ann Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-020-02393-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-020-02393-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-020-02393-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T23:35:20Z","timestamp":1622072120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-020-02393-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,27]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["2393"],"URL":"https:\/\/doi.org\/10.1007\/s12094-020-02393-9","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,27]]},"assertion":[{"value":"7 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all patients included in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}